94
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Preexposure of MCF-7 breast cancer cell line to dexamethasone alters the cytotoxic effect of paclitaxel but not 5-fluorouracil or epirubicin chemotherapy

, , , &
Pages 171-175 | Published online: 16 Mar 2017

References

  • RosenJMinerJNThe search for safer glucocorticoid receptor ligandsEndocr Rev200526345246415814846
  • KoflerRThe molecular basis of glucocorticoid-induced apoptosis of lymphoblastic leukemia cellsHistochem Cell Biol200011411710959816
  • Evans-StormsRBCidlowskiJADelineation of an antiapoptotic action of glucocorticoids in hepatoma cells: the role of nuclear factor-kappaBEndocrinology2000141518541862
  • Bernard-MartyCCardosoFPiccartMJUse and abuse of taxanes in the management of metastatic breast cancerEur J Cancer200339141978198912957452
  • MichaJPRettenmaierMABrownJV3rdA randomized controlled pilot study comparing the impact of aprepitant and fosaprepitant on chemotherapy induced nausea and vomiting in patients treated for gynecologic cancerInt J Gynecol Cancer201626238939326588232
  • CoatesASWinerEPGoldhirschATailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015Ann Oncol20152681533154625939896
  • SenkusEKyriakidesSOhnoSPrimary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnn Oncol201526Suppl 5v8v3026314782
  • SkorMNWonderELKocherginskyMGlucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancerClin Cancer Res201319226163617224016618
  • LienHCLuYSChengALDifferential expression of glucocorticoid receptor in human breast tissues and related neoplasmsJ Pathol2006209331732716639692
  • BuxantFEngohan-AlogheCNoëlJCEstrogen receptor, progesterone receptor, and glucocorticoid receptor expression in normal breast tissue, breast in situ carcinoma, and invasive breast cancerAppl Immunohistochem Mol Morphol201018325425719875955
  • VilascoMCommunalLHugon-RodinJLoss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissueBreast Cancer Res Treat2013142228329624166279
  • BuxantFKindtNLaurentGNoëlJCSaussezSAntiproliferative effect of dexamethasone in the MCF-7 breast cancer cell lineMol Med Rep20151234051405426080744
  • LippmanMBolanGHuffKThe effects of glucocorticoids and progesterone on hormone-responsive human breast cancer in long-term tissue cultureCancer Res19763612460246091000505
  • LeoJCGuoCWoonCTAwSELinVCGlucocorticoid and mineralocorticoid cross talk with progesterone receptor to induce focal adhesion and growth inhibition in breast cancer cellsEndocrinology200414531314132114617569
  • KhanSLopez-DeeZKumarRLingJActivation of NFkB is a novel mechanism of pro-survival activity of glucocorticoids in breast cancer cellsCancer Lett20133371909523693080
  • SchorrKFurthPAInduction of bcl-xL expression in mammary epithelial cells is glucocorticoid-dependent but not signal transducer and activator of transcription 5-dependentCancer Res200060215950595311085510
  • WuWChaudhuriSBrickleyDRPangDKarrisonTConzenSDMicroarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cellsCancer Res20046451757176414996737
  • WuWPewTZouMPangDConzenSDGlucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survivalJ Biol Chem200528064117412415590693
  • RutzHPEffects of corticosteroid use on treatment of solid tumoursLancet200236093491969197012493280
  • GotaskieGEAndreassiBFPaclitaxel: a new antimitotic chemotherapeutic agentCancer Pract19942127337914453
  • HaldarSBasuACroceCMBcl2 is the guardian of microtubule integrityCancer Res19975722292339000560
  • PinedoHMPetersGFFluorouracil: biochemistry and pharmacologyJ Clin Oncol1988610165316643049954
  • WangFLiuXLiuCLiuZSunLEffects of antibiotic antitumor drugs on nucleotide levels in cultured tumor cells: an exploratory method to distinguish the mechanisms of antitumor drug action based on targeted metabolomicsActa Pharm Sin B20155322323026579450
  • LuoHTuGLiuZLiuMCancer-associated fibroblasts: a multifaceted driver of breast cancer progressionCancer Lett2015361215516325700776
  • CatteauXSimonPNoëlJCStromal expression of matrix metalloproteinase 2 in cancer-associated fibroblasts is strongly related to human epidermal growth factor receptor 2 status in invasive breast carcinomaMol Clin Oncol20164337537826998286
  • WangJZhangHSuCDexamethasone ameliorates H2S-induced acute lung injury by alleviating matrix metalloproteinase-2 and -9 expressionPLoS One201494e9470124722316
  • OrquedaAJDanseyMVEspañolAThe rigid steroid 21-hydroxy-6,19-epoxyprogesterone (21OH-6,19OP) is a dissociated glucocorticoid receptor modulator potentially useful as a novel coadjuvant in breast cancer chemotherapyBiochem Pharmacol201489452653524735610